![igc-ad1](https://investor.igcpharma.com/wp-content/uploads/2024/04/PR-AD_01-min-1024x1024.jpg)
June 21, 2022
IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate
Facebook
Twitter
LinkedIn